Target Name: SPAG11B
NCBI ID: G10407
Review Report on SPAG11B Target / Biomarker Content of Review Report on SPAG11B Target / Biomarker
SPAG11B
Other Name(s): HE2C | SPAG11 | EP2C | human epididymis-specific protein 2 | sperm antigen HE2 | Epididymal protein 2B | EP2 | Protein EP2 | Sperm-associated antigen 11B | HE2 | sperm associated antigen 11B | EDDM2B | epididymal protein 2B | Sperm antigen HE2 | Sperm associated antigen 11B, transcript variant D | He2 | SPAG11A | Human epididymis-specific protein 2 | Sperm-associated antigen 11A | SPAG11B variant D | SG11B_HUMAN | EP2D | Sperm-associated antigen 11B (isoform D) | beta1

SPAG11B: A Protein of Great Interest as a Drug Target and Biomarker

SPAG11B (HE2C) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the SPAG family of proteins, which are known for their role in cell signaling. While the exact function of SPAG11B is not yet fully understood, research has suggested that it may be involved in a number of important cellular processes, including cell adhesion, migration, and signaling.

One of the key challenges in studying SPAG11B is its complex structure. While the protein is known to have several known functions, it is not clear how these functions are achieved. This is particularly problematic because SPAG11B is a member of a family of proteins that are known for their ability to interact with one another in complex ways. It is possible that SPAG11B functions as a key regulator of these interactions, but more research is needed to determine this.

In addition to its potential role in cell signaling, SPAG11B is also of interest as a potential drug target. The ability of this protein to interact with other proteins suggests that it may play a role in the regulation of cellular processes that are important for human health. For example, SPAG11B has been shown to be involved in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs.

Another potential application of SPAG11B as a drug target is its role in the regulation of cell migration. SPAG11B has been shown to be involved in the regulation of cell movement, which is important for the development and maintenance of tissues and organs. This suggests that it may be a useful target for drugs that are designed to promote or inhibit cell migration.

In addition to its potential role in drug development, SPAG11B is also of interest as a potential biomarker. The regulation of SPAG11B has been shown to be involved in a number of important cellular processes, which suggests that it may be a useful indicator of the health and function of certain tissues. For example, SPAG11B has been shown to be involved in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs. This suggests that SPAG11B may be a useful biomarker for the diagnosis and treatment of diseases that are characterized by the disruption of cell adhesion.

Overall, SPAG11B is a protein that is of great interest as a potential drug target and biomarker. While more research is needed to fully understand its functions and potential applications, its complex structure and involvement in cell signaling suggest that it may be a valuable tool for the development of new treatments for a variety of diseases.

Protein Name: Sperm Associated Antigen 11B

Functions: Has antimicrobial activity against E.coli (By similarity). Plays a role in the defense response in the male reproductive tract, contributing to sperm maturation, storage and protection (By similarity)

The "SPAG11B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPAG11B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SPAG16 | SPAG16-DT | SPAG17 | SPAG4 | SPAG5 | SPAG5-AS1 | SPAG6 | SPAG7 | SPAG8 | SPAG9 | SPAM1 | SPANXA1 | SPANXA2-OT1 | SPANXB1 | SPANXB2 | SPANXC | SPANXD | SPANXN1 | SPANXN2 | SPANXN3 | SPANXN4 | SPANXN5 | SPARC | SPARCL1 | SPART | SPART-AS1 | SPAST | SPATA1 | SPATA12 | SPATA13 | SPATA13-AS1 | SPATA16 | SPATA17 | SPATA18 | SPATA19 | SPATA2 | SPATA20 | SPATA20P1 | SPATA21 | SPATA22 | SPATA24 | SPATA25 | SPATA2L | SPATA3 | SPATA3-AS1 | SPATA31A1 | SPATA31A2 | SPATA31A3 | SPATA31A5 | SPATA31A6 | SPATA31A7 | SPATA31C1 | SPATA31C2 | SPATA31D1 | SPATA31D3 | SPATA31E1 | SPATA32 | SPATA33 | SPATA4 | SPATA41 | SPATA42 | SPATA45 | SPATA46 | SPATA48 | SPATA5 | SPATA5L1 | SPATA6 | SPATA6L | SPATA7 | SPATA8 | SPATA8-AS1 | SPATA9 | SPATC1 | SPATC1L | SPATS1 | SPATS2 | SPATS2L | SPC24 | SPC25 | SPCS1 | SPCS2 | SPCS2P4 | SPCS3 | SPDEF | SPDL1 | SPDYA | SPDYC | SPDYE1 | SPDYE18 | SPDYE2 | SPDYE21 | SPDYE2B | SPDYE3 | SPDYE4 | SPDYE5 | SPDYE6 | SPDYE7P | SPDYE8 | SPDYE9 | SPECC1